Tau hyperphosphorylation at several sites, including those close to the microtubule domain region (MDr), is considered a key pathological event in the development of Alzheimer's disease (AD). Recent studies indicate that at the very early stage of this disease, increased phosphorylation in Tau's MDr domain correlates with reduced levels of neuronal excitability. Mechanistically, we show that pyramidal neurons and some parvalbumin-positive interneurons in 1-month-old triple-transgenic AD mice accumulate hyperphosphorylated Tau protein and that this accumulation correlates with changes in theta oscillations in hippocampal neurons. Pyramidal neurons from young triple-transgenic AD mice exhibited less spike accommodation and power increase in subthreshold membrane oscillations. Furthermore, triple-transgenic AD mice challenged with the potassium channel blocker 4-aminopyridine had reduced theta amplitude compared with 4-aminopyridine-treated control mice and, unlike these controls, displayed no seizure-like activity after this challenge. Collectively, our results provide new insights into AD pathogenesis and suggest that increases in Tau phosphorylation at the initial stages of the disease represent neuronal responses that compensate for brain circuit overexcitation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986208PMC
http://dx.doi.org/10.1074/jbc.RA117.001187DOI Listing

Publication Analysis

Top Keywords

triple-transgenic mice
12
tau protein
8
correlates changes
8
theta oscillations
8
pyramidal neurons
8
phosphorylation tau
4
protein correlates
4
changes hippocampal
4
hippocampal theta
4
oscillations reduces
4

Similar Publications

The total withanolides from the leaves of Datura stramonium L. Improves Alzheimer's disease pathology by restraining neuroinflammation through NLRP3/IL-1β/IL1R1/TOM 1 pathway.

Int Immunopharmacol

December 2024

Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, China; Traditional Chinese Medicine (TCM) Biological Genetics (Heilongjiang Province Double First-class Construction Interdiscipline, China. Electronic address:

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the deposition of beta-amyloid (Aβ) peptides. Microglia-mediated neuroinflammation is one of the primary contributors to the pathogenesis of AD. Withanolides, the main constituents in the leaves of Datura stramonium L.

View Article and Find Full Text PDF

Behavioral testing is an essential tool for evaluating cognitive function and dysfunction in preclinical research models. This is of special importance in the study of neurological disorders such as Alzheimer's disease. However, the reproducibility of classic behavioral assays is frequently compromised by interstudy variation, leading to ambiguous conclusions about the behavioral markers characterizing the disease.

View Article and Find Full Text PDF
Article Synopsis
  • The choroid plexus (CP) and blood-cerebrospinal fluid-barrier (BCSFB) play a critical role in producing and clearing cerebrospinal fluid, and their dysfunction is linked to neurodegenerative diseases like Alzheimer's disease (AD).
  • This study utilized advanced MRI techniques to measure water delivery across the BCSFB in a triple transgenic mouse model of AD, observing significant changes in CP function even before clinical symptoms appear.
  • Results indicated increased BCSFB-mediated water delivery in younger mice, with notable behavioral differences arising around 20 weeks, suggesting that CP changes could serve as early biomarkers for AD.
View Article and Find Full Text PDF

Spatial and planar profiling of Rac1/Cdc42 signaling in Alzheimer's disease brain.

J Alzheimers Dis

December 2024

Department of Anatomy and Cell Biology, Brody School of Medicine, East Carolina University, Greenville, NC, USA.

Article Synopsis
  • - The study focuses on the dysregulation of small GTPases Rac1 and Cdc42 in Alzheimer's disease (AD), which are important for maintaining synaptic structures and could be potential therapeutic targets.
  • - Researchers used specific antibodies to assess the activity levels of Rac1/Cdc42 and their downstream effects in brains from a triple transgenic mouse model and human AD samples.
  • - Results showed that Rac1/Cdc42 activity changes vary across different regions of the brain, with decreased activity in certain areas of AD-affected mice and variations also noted in human AD samples, indicating a complex relationship with the disease's progression.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!